SIDEfxHUB
The charity provides funds for research to increase understanding or the cause and treatment of Post Finasteride Syndrome and other Iatrogenic diseases for the benefit of sufferers without geographical limit
Objects
TO PROMOTE SCIENTIFIC RESEARCH INTO THE PREVENTION, CURE, MANAGEMENT AND ALLEVIATION OF IATROGENIC DISEASE, INCLUDING BUT NOT LIMITED TO POST FINASTERIDE SYNDROME, BY PROVIDING FUNDING ON CONDITION THAT THE USEFUL RESULTS OF SUCH RESEARCH MUST BE DISSEMINATED FOR THE PUBLIC BENEFIT.IATROGENIC DISEASE MEANS A CONDITION DUE TO EXPOSURE TO PATHOGENS, TOXINS OR INJURIOUS TREATMENT OR PROCEDURES.POST FINASTERIDE SYNDROME REFERS TO THE PHYSICAL, NEUROLOGICAL AND SEXUAL SYMPTOMS THAT MAY OCCUR IN PERSONS AFTER THEY STOP TAKING FINASTERIDE OR OTHER 5-ALPHA REDUCTASE INHIBITORS.
Financial health, per its FY2025 accounts
The accounts state that the charity held unrestricted reserves of £2,924.85 against a policy target of approximately £1,500 (12 months of running costs). The trustees note they are awaiting decisions regarding future research donations while managing reserves prudently.
What the accounts disclose
“Trustees aim to hold unrestricted reserves equivalent to approximately 12 months of running costs (c. £1,500).” — page 5
Policies the charity declares
- Complaints handling
- Complaints policy and procedures
- Financial reserves policy and procedures
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Social media policy and procedures
Trustees
- Gary Shieldschair
- Katharine Hayden
- Robert Dixon
- Ryan Clark
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 01/08/2025 | £403k | £1k |
| 01/08/2024 | £31k | £27k |
Common questions
Is SIDEfxHUB financially healthy?
Per its FY2025 accounts: The accounts state that the charity held unrestricted reserves of £2,924.85 against a policy target of approximately £1,500 (12 months of running costs). The trustees note they are awaiting decisions regarding future research donations while managing reserves prudently. Its FY2025 accounts were independently examined.